Tesidolumab Biosimilar - Research Grade

Human

C5ï؟½

5mg/ml

IgG1 - lambda2

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P01031

Blue ice

Complement component C5 sits at the core of the terminal complement pathway, and its inhibition is a major theme in complement-mediated disease research. This product is a research-grade, unconjugated analog of tesidolumab, a recombinant anti-C5 monoclonal antibody for research use only. Manufactured to in vivo standards with low endotoxin, it is available in scalable milligram to gram quantities for bulk and high-throughput laboratories. The antibody suits complement-inhibition functional assays, in vitro hemolysis screens, and in vivo models of complement-driven disease. Lot-to-lot reproducibility and ample availability make it well suited to extended, high-volume research efforts.

REGN3918,REGN-3918,complement 5, C5a anaphylatoxin

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks